Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for double-J stent discomfort
KCT0002599Phase 3Recruiting
- Sponsor
- Korea University Ansan Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in Lithiasis, ureteral stent-related symptoms (USRS), sponsored by Korea University Ansan Hospital. Started Aug 2017; status: recruiting.
02
Drugs
mirabegron
03
Conditions
Lithiasisureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on KCT0002599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002599.